descent or oxygen treatment. The main differential diagnoses are pneumonia, pulmonary embolism, and left heart failure. In a Colombian study of 13 cases of HAPE the initial diagnosis was bronchopneumonia in children and myocarditis or coronary insufficiency in adults. 8 Excessive speed of ascent is a major contributing factor to HAPE. In a group of 166 cases 65% took less than two days to reach the altitude at which they developed HAPE, and HAPE occurred before the fifth day in 73% of cases. Mortality was higher in subjects treated by descent alone (12%) than in those treated with oxygen alone (5%), or both (3%); those not treated had a mortality rate of 44%.13 Who can suffer from HAPE? The risk of developing altitude sickness occurs in many human activities including climbing, trekking, skiing, touring, and working at high altitude. HAPE can occur in people residing at high altitude (in the Andean Altiplano and in Colorado) who return from a few days' stay at a lower altitude ("re-entry" oedema). 1 5 The incidence was 0-6% in adults and 8-9% in children in Peru in the 1970s. '5 Mountaineers climbing high peaks in the Himalayas, the Andes, and also in Europe (Mont-Blanc, Monte Rosa), North America (Colorado, Alaska), and Africa (Mount Kenya, Kilimanjaro) are prone to develop HAPE, especially when they do not take enough time to acclimatise themselves to the altitudes between 2500 and 4500 M."3 A typical example is an alpinist arriving at a base camp around 5000 m, excited by the idea ofclimbing the mountain, going up to a high altitude camp, expending a lot of energy, feeling tired and dyspnoeic, and found dead the next morning in his tent. Cases are often observed in less severe conditions such as ski resorts in the Alps'617 and Colorado, '8 It is my opinion. ... The rapid evolution of the lung inflammation can only be explained by the influence of mountain sickness on the weakening of the heart and on the energy of the nervous system of this young man, formerly so robust".27
In 1913 Ravenhill, a medical officer in a mining company in Chile, described a "puna" (AMS) of "the cardiac type", with dyspnoea, rales and cyanosis, which he defined as an acute heart condition coming on in a perfectly healthy man and disappearing rapidly with descent. 28 Animal studies have been conducted since 1925 to understand better the effect of hypoxia on the lung morphology and function. Oedema, more often interstitial than clearly alveolar, has been reported by several authors, but the mechanisms of its formation are not known. 29 32 A case of pulmonary oedema was described by Hurtado in 1937 but the patient probably had pre-existing cardiac disease since signs of "circulatory insufficiency" (peripheral oedema, dyspnoea, congestion of lung bases) were still present long after his acute episode had subsided.3
If we defined HAPE as a pulmonary oedema occurring at high altitude in a subject where signs of pneunomia and cardiac failure have been discarded, then the first clear description of this syndrome appeared in the 1950s and was published in Spanish in Peruvian publications. and overperfusion are necessary to produce pulmonary oedema in dogs. 48 In fact, systemic hypertension is not associated with HACE or AMS, whereas pulmonary hypertension, when observed before treatment in the acute phase of the disease, is always present in HAPE. Inversely, HAPE is not always preceded by clinical signs of AMS. Severe cases of AMS with peripheral, pulmonary, and cerebral oedema have been associated with hypoventilation, weight gain and decreased urine output, suggesting a common pathogenesis involving fluid retention.4549 Thus "high altitude (HA) illness" has been suggested to be a general problem of water handling leading to water retention and transfer of fluid from intravascular to interstitial and intracellular compartments. The "high-pressure high-flow" hypothesis is advocated: systemic hypertension and cerebral vasodilation induce HACE, pulmonary hypertension and high cardiac output induce HAPE, and cutaneous vasodilation and systemic hypertension induce peripheral oedema. However, four facts go against this hypothesis: (1) cerebral oedema can appear without exercise -that is, without systemic hypertension; (2) pulmonary oedema can occur without high flow -that is, without exercise; (3) there is no cutaneous vasodilation at high altitude; and (4) severe normoxic exercise is associated with high pressure and high flow and does not produce pulmonary or cerebral oedema, even if exercise-induced arterial hypoxaemia occurs in healthy subjects at sea level.50 There are anecdotal reports of pulmonary oedema in marathon runners but these are associated with water intoxication. However, peripheral oedema has also been found to occur with prolonged exercise at low altitude.5"
Experimental evidence of hypoxia-induced increase in capillary permeability was first shown by Landis in 1932.52 Thereafter, studies gave conflicting results. Some authors showed experimental evidence of increased lung vascular permeability,4853-59 while others failed to show any increase in vascular permeability or oedema formation in the lung.60-65 Increased transvascular clearance ofradiolabelled albumin was found in humans at high altitude, associated with proteinuria,66 which suggests a general increased permeability.67 The contradictions observed may be due to species differences, experimental design, or sensitivity of the method used. Pigs and rats seem more sensitive to pulmonary oedema than sheep or dogs.68 However, Viswanathan found a similar incidence of HAPE in dogs and rats and a higher incidence in mice. Thus, an increase in PAP is probably necessary but not sufficient to induce HAPE. The concept of uneven vasoconstriction is questioned by the findings ofVock et al concerning the evolution of radiographic images from "patchy" to "homogeneous" and clinical findings suggesting that structural abnormalities are not involved in the pathogenesis.7 However, this concept was recently supported by the studies of West and coworkers who showed that a hydrostatic stress, possibly comparable to that evaluated in HAPE, could break the lung endothelium and epithelium barrier in a model of an isolated rabbit lung.9293 These alterations are less marked after reoxygenation. 94 The disruption of the endothelium would expose the basal membrane and activate the release of inflammatory mediators such as thromboxane B2.95 This "mechanistic view" or "stress failure" hypothesis of HAPE is comparable with other diseases or manifestations such as Goodpasture's syndrome with alteration ofbasal membrane, haemorrhages in race horses, and disorders in mechanically hyperventilated patients. 96 The mechanical damage is the primary cause, after which permeability is increased by the release of mediators.
As the concepts of the physiopathology of HAPE have developed, another aspect has expanded in parallel which suggests that the primary insult is the alteration of the endothelium, either by a direct effect of hypoxia or by the release of mediators acting on inflammation processes, vascular permeability, and vasomotor responses. In favour of this "cellular view" or "high permeability" hypothesis are the many experimental studies that show a hypoxiainduced increase in peripheral or pulmonary vascular permeability, the frequent association with oedema in other organs with the absence of systemic hypertension, the composition of alveolar fluid with a high protein content and mediators of inflammation, the frequent occurrence of HAPE at rest and often during sleep, the rapid reversibility of HAPE when oxygen availability is rapidly restored, and the common finding of interstitial oedema and altered oxygen transfer in the lung of normal subjects at high altitude. However, as already mentioned, some studies have failed to show any hypoxia-induced increase in capillary permeability, and the composition of alveolar fluid is also compatible with the "stress failure" hypothesis, leading to a leakage of fluid and proteins into the interstitium. The fibrin-rich alveolar oedema found at nec-ropsy supports the hypothesis of capillary damage83 or increased capillary permeability.97 Subclinical interstitial pulmonary oedema is a common finding in newcomers to high altitude, without HAPE.8698-100 In 1978 Staub hypothesised that shear stress-induced alteration of endothelium leads to a leakage of fluid into the interstitium.101
The effects of hypoxia on the endothelial cell permeability was investigated by Ogawa et al.l02 Cultured bovine endothelium in monolayers were exposed to a Po2 of about 2 kPa. The permeability to macromolecules was increased in a time-dependent and dose-dependent manner. A significant increase was shown after 24-48 hours with a maximum at 72 hours. It was reversible within 48 hours of reoxygenation. These changes were associated with morphological alterations -namely, larger cells and the presence of intercellular gaps. Thrombomodulin activity (a cell surface anticoagulant cofactor) was inhibited by hypoxia and reversed by reoxygenation.
The effects of hypoxia on pulmonary vascular leakage was investigated in rats by Stelzner et al.59 Rats were exposed for 1-48 hours at 60 kPa. The authors showed an increase in transvascular protein leakage that was inhibited by glucocorticoid pretreatment, augmented by adrenalectomy, and independent of pulmonary arterial pressure. This phenomenon was not seen for short exposures (1-13 hours), was similar in normobaric or hypobaric hypoxia, and was associated with increased lung water and perivascular oedema cuffs on histological examination. by pretreatment with anti-adhesion molecule substances. Both experimental and human studies have shown a hypoxia-induced increase in plasma endothelin levels. In a study of 10 subjects plasma levels of endothelin were increased by 51 % after one week of exposure to 6542 m. By contrast, moderate or severe exercise failed to stimulate endothelin release and the exercise-induced increase in plasma renin activity was inversely related to plasma endothelin levels.""213 In a study at the Observatoire Vallot endothelin levels increased by 82% after five days at 4350 m; in addition, plasma levels of ELAM-1, but not ICAM-1, were also increased."3 A third hypothesis was developed in the 1 970s, by analogy with traumatic neurogenic pulmonary oedema."4 A sudden discharge in the adrenergic system would lead to pulmonary oedema, either by pulmonary venous constriction or left heart failure due to systemic hypertension. Neurogenic pulmonary oedema could also be directly mediated by a permeability defect."5 The only positive argument in favour of this theory is the beneficial effect of oc blockers in HAPE subjects."6
The conclusion drawn by Oelz et al in 1989 for the pathophysiology of HAPE is "permeability oedema in which hypoxic pulmonary hypertension is a crucial factor by enhancing the flow ofliquid across the damaged endothelial barrier". 117 HAPE: vascular or epithelial leak? It is important to consider that vascular permeability to fluid is a normal physiological process described by Starling's equation.'0' Moreover, many individuals develop pulmonary interstitial oedema or subcutaneous oedema at high altitude without HAPE. Fishman stressed the role of the alveolar rather than the endothelial barrier, and the role of lymphatic drainage in limiting interstitial oedema. 118 Pulmonary interstitial oedema occurs with a small increase in vascular hydrostatic pressure. Compliance oflung vessels and interstitium is high, and only a 5-8% increase in lung weight is associated with peribronchovascular oedema. As much as a 35% increase in lung weight is necessary for alveolar oedema. Epithelial permeability is 10 times less than endothelial permeability which makes the epithelium a much stronger barrier than the endothelium. The question arises, however, whether the alveolar epithelium rather than the capillary endothelium is the limiting factor in the development of alveolar oedema.
Recent studies indicate that certain pneumocyte functions may be altered in hypoxia."9120 Sodium transport by the alveolar epithelium represents an important mechanism for clearance of airspace fluid in acute lung injury. We have examined whether hypoxia affects Na,K- HAPE, nifedipine decreased PAP and slightly decreased systemic arterial pressure, but had no effect on Pao2 and AMS; thus, nifedipine or isradipine cannot be recommended for prevention of benign AMS. '28 129 The rationale for the use of oc blockers is based on neurogenic pulmonary oedema with massive adrenergic discharge. It was shown to be efficient in field situations, with or without oxygen."6 Prevention depends on slow ascent for progressive acclimatisation, rest after ascent, clinical education, and early recognition of symptoms. The detection of HAPEsusceptible subjects with appropriate hypoxic tests should be encouraged.75
Inhaled nitric oxide (NO) has recently been used to treat HAPE at 4559 m.'3 Its vasorelaxant action on the pulmonary vasculature, associated with its rapid inactivation within the circulation by haemoglobin which prevents any peripheral action, are interesting features. However, it is not yet of practical use in the field.
New developments There are two main barriers to a better understanding of HAPE: (1) the lack of a good animal model of hypoxiainduced alveolar oedema, and (2) the difficulty of performing controlled studies in patients suffering from HAPE in remote areas, far from hospital facilities. Non-invasive studies of the pulmonary circulation could help us to understand the time dependence of pulmonary hypertension with the appearance of HAPE. Is alveolar oedema the cause or the consequence of pulmonary hypertension? Molecular biology could also help by providing information about the eventual role of hypoxic sensing dysfunction. Hypoxic sensing can be seen in chemoreceptors, in EPOproducing cells, and in vessels producing vasoconstriction in the lungs and vasodilation in the periphery.'3' Hypoxia is most probably sensed at the molecular level and upregulates the expression of several genes, especially coding for EPO, endothelin, or vascular endothelial growth factor (also known as vascular permeability factor). 131 Studies on these molecular mechanisms may provide further insight into the pathophysiology of HAPE and in the susceptibility of individuals to develop the condition.
In-breeding studies in cattle have shown that the responsiveness of the pulmonary circulation to hypoxia is genetically coded.'32 Anecdotal reports of a familial predisposition to HAPE6142840 need further investigations in humans. Genetic characteristics of HAPE could be explored with new generations of young alpinists.
Conclusions
The hypoxic challenge triggers important changes in both the pulmonary and the peripheral circulation systems. Increased interstitial or tissue oedema is the main feature of altitude-induced hypoxia. An exacerbation of the permeability properties of the endothelium could be directly mediated by hypoxia or by substances released locally. In the pulmonary circulation hypoxic arteriolar vasoconstriction and pulmonary hypertension interfere with the increased vascular permeability. Interstitial oedema has only limited functional consequences, but when oedema develops within the alveoli or the brain severe consequences may result. The precise mechanisms by which lung interstitial oedema turns into alveolar oedema remain to be elucidated by further studies on epithelial function. '33 Individual susceptibility to the condition also deserves further investigation so that better means of prevention and treatment can be developed. 
